v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 343 $ 534 $ 787 $ 829
Cost of revenue 276 297 525 428
Gross profit 67 237 262 401
Operating expenses:        
Selling, general and administrative 2,085 2,115 5,941 5,842
Research and development 1,435 1,989 5,211 6,375
Total operating expenses 3,520 4,104 11,152 12,217
Loss from operations (3,453) (3,867) (10,890) (11,816)
Other income and expense, net (315) 234 (271) 896
Loss from operations before income taxes (3,768) (3,633) (11,161) (10,920)
Net loss $ (3,768) $ (3,633) $ (11,161) $ (10,920)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 1,677 1,665 1,676 1,663
Basic and diluted net loss per common share:        
Net loss per common share (in dollars per share) $ (2.25) $ (2.18) $ (6.66) $ (6.57)
Other comprehensive loss, net of tax:        
Net loss $ (3,768) $ (3,633) $ (11,161) $ (10,920)
Available-for-sale securities:        
Net unrealized gain (loss) 159 139 476 236
Total comprehensive loss $ (3,609) $ (3,494) $ (10,685) $ (10,684)